ArticleACS omega2025
Structural and Chemical Modification of Cellular Wood Composite for Enhanced Strength, Fire, and Biological Resistance.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-performance cellular wood composites with enhanced strength, flame retardancy, and termite resistance were developed through delignification, densification, and impregnation with amino-functionalized polyglycerol phosphate (APGP) and disodium octaborate tetrahydrate (DOT). Compared with the performance of control samples, the flexural strength of treated wood samples increased by 56%. Flame resistance was enhanced with increased char yield (from <1 to 42.6%), improved limiting oxygen index value (from 23 to 56%), and a reduction in peak heat release rate (127 to 48 W/g). Termite resistance was also enhanced, with the sample weight loss reduced from 83.75 to 30.45% and termite mortality increased from less than 20 to 100% after 56 day testing. These improvements were attributed to a dual-phase flame-retardant mechanism involving gas-phase intumescent char formation by APGP and solid-phase B
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.